AIM releases new educational podcasts on its individual safety website section American Imaging Administration, Inc. , a respected diagnostic imaging benefit administration and technology company with health plan customers representing more than 35 million customers and an working subsidiary of WellPoint, Inc . Thomas Power, MD, FACC, MRCPI, AIM’s medical director for Cardiology, the latest group of podcasts discuss radiation exposure associated with cardiac imaging techniques including Cardiac Computerized Tomography . Power.’ Related StoriesNon-invasive diagnostic imaging can eliminate CAD in about 50 percent of females with atypical chest painResearchers report brand-new breakthrough in countering deadly ramifications of radiation exposureStudy looks at impact of amyloid imaging on medical diagnosis, management of patients with cognitive impairmentPodcasts are the latest element of AIM’s Patient Safety Program.

Unlike almost every other bispecific molecules that are built using genetic fusion, the two scFvs that compose AZ17 are conjugated covalently using a synthetic linker. This simultaneous inhibition of two independent Th17 cytokines represents a novel approach to treating Th17 connected diseases such as for example multiple sclerosis, Crohn’s and psoriasis.. ALLOZYNE’s AZ17 antagonist displays positive data for treatment of autoimmune diseases ALLOZYNE Inc. Announced today positive data from preclinical studies evaluating AZ17 which really is a novel bispecific Th17 antagonist that inhibits the differentiation and effector function of human Th17 cells in vivo. Outcomes from these research demonstrated AZ17 to have got improved efficacy over individual parental antibodies in addition to high potency and affinity for each respective target.